March 21 (Reuters) - Cidara Therapeutics Inc:
* CIDARA THERAPEUTICS PROVIDES CLINICAL DATA UPDATES FOR ITS LEAD ANTIFUNGAL REZAFUNGIN
* CIDARA THERAPEUTICS - ADDITIONAL DATA AND ANALYSES FROM STRIVE PHASE 2 CLINICAL TRIAL CONFIRM POSITIVE EFFICACY RESULTS IN BOTH REZAFUNGIN ARMS Source text for Eikon: Further company coverage: